Abstract: Disclosed herein are compositions and methods for use in therapeutic procedures. Use of a “fast-acting” botulinum toxin for cosmetic treatment and/or to prevent or reduce scarring. “Fast-acting” refers to a botulinum toxin that produces effects in the patient more rapidly than those produced by, for example, a botulinum neurotoxin type A. The “fast-acting” botulinum toxin, for example, type E.
Type:
Grant
Filed:
March 22, 2018
Date of Patent:
March 1, 2022
Assignee:
Bonti, Inc.
Inventors:
Sawsan Abushakra, Wajdie Ahmad, Fauad Hasan, Michael Jarpe